Martin P. Rosendale is CEO at CYTOMEDIX INC (CMXI). They have made 10 open-market trades across 2 companies since 2008, most recently 2014-08-20.
CIK 0001430354
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
10 open-market purchases totalling $93K since 2008, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CMXI | BUY | 2014-08-20 | 2014-08-21 | $0.40 | $10K | N/A | N/A | N/A |
| CMXI | BUY | 2013-04-04 | 2013-04-05 | $0.52 | $9K | N/A | N/A | N/A |
| CMXI | BUY | 2013-02-22 | 2013-02-22 | $0.53 | $11K | N/A | N/A | N/A |
| CMXI | BUY | 2012-07-03 | 2012-07-03 | $1.15 | $9K | N/A | N/A | N/A |
| CMXI | BUY | 2011-03-31 | 2011-03-31 | $0.36 | $7K | N/A | N/A | N/A |
| GTF | BUY | 2009-08-14 | 2009-08-14 | $0.57 | $10K | N/A | N/A | N/A |
| GTF | BUY | 2009-05-22 | 2009-05-26 | $0.52 | $2K | N/A | N/A | N/A |
| GTF | BUY | 2009-01-07 | 2009-01-08 | $0.39 | $2K | N/A | N/A | N/A |
| GTF | BUY | 2008-09-05 | 2008-09-09 | $0.75 | $25K | N/A | N/A | N/A |
| GTF | BUY | 2008-04-03 | 2008-04-03 | $0.85 | $9K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.